1. Home
  2. NUVL vs ARW Comparison

NUVL vs ARW Comparison

Compare NUVL & ARW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$103.39

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Arrow Electronics Inc.

ARW

Arrow Electronics Inc.

HOLD

Current Price

$132.77

Market Cap

5.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
ARW
Founded
2017
1935
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
5.8B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
ARW
Price
$103.39
$132.77
Analyst Decision
Strong Buy
Sell
Analyst Count
15
2
Target Price
$135.00
$102.00
AVG Volume (30 Days)
581.9K
540.6K
Earning Date
02-26-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.79
EPS
N/A
9.05
Revenue
N/A
$29,389,382,000.00
Revenue This Year
N/A
$9.50
Revenue Next Year
N/A
$4.28
P/E Ratio
N/A
$14.68
Revenue Growth
N/A
3.16
52 Week Low
$55.54
$86.50
52 Week High
$113.02
$134.74

Technical Indicators

Market Signals
Indicator
NUVL
ARW
Relative Strength Index (RSI) 48.27 76.39
Support Level $100.19 $115.75
Resistance Level $107.51 $120.00
Average True Range (ATR) 4.89 3.48
MACD -0.41 1.77
Stochastic Oscillator 36.14 94.56

Price Performance

Historical Comparison
NUVL
ARW

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About ARW Arrow Electronics Inc.

Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.

Share on Social Networks: